Pediatrics News

Otsuka and Lundbeck have announced FDA acceptance of a supplemental new drug application for Rexulti for the treatment of schizophrenia in adolescents.

Prescription digital therapeutic company Limbix announced the launch of a digital tool for teens and young adults with depression symptoms.

Daily intranasal therapy with the hormone oxytocin did not appear to improve social functioning among children with autism spectrum disorder, according to an NIH-funded study, contradicting smaller studies supporting its off-label use.

The COVID-19 pandemic has led to significant changes in the dynamics of children’s suicide attempts, according to results of a cross-sectional study published in JAMA Network Open.

Motivational interviewing during specialized pediatric consultations did not increase mental health care service use among adolescents and young adults with chronic medical conditions, according to a cluster randomized clinical trial.

Recreational ketamine use and availability have increased in the U.S. in recent years, despite still being an uncommon drug, according to study results published in American Journal of Public Health.

More than one-third of children on Medicaid in the foster care system were prescribed psychotropic medications, a higher amount than children on Medicaid outside the system, according to an AAP National Conference & Exhibition presentation.

College age students reported issues with distance learning during the COVID-19 pandemic, including trouble concentrating, limited access to technology, food insecurity, and mental health issues, according to researchers.

Individuals who were bullied by their siblings in early adolescence had increased risk for poor mental health later in adolescence, according to a prospective longitudinal study in Journal of Youth and Adolescence.

How infants spontaneously play in their daily environments may help them develop everyday learning faculties and grow cognitive, social and language abilities, according to a study published in Child Development.